 | Brainstorm Cell Therapeutics (NASDAQ:BCLI) Shares Down 6.4%
americanbankingnews.com - February 25 at 8:18 PM |
 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
prnewswire.com - February 24 at 8:24 PM |
 | BrainStorm to Present at SVB Leerink 10th Global Healthcare Conference
finance.yahoo.com - February 23 at 8:19 AM |
| Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Brainstorm Cell Therapeutics Inc. (BCLI) Investigation
finance.yahoo.com - February 22 at 7:56 PM |
| FDA Concludes BrainStorm's ALS Cell Therapy Lacks Substantial Data For Submission; Shares Drop
finance.yahoo.com - February 22 at 2:55 PM |
| BrainStorm Announces High-Level FDA Feedback on NurOwn® ALS Clinical Development Program
finance.yahoo.com - February 22 at 9:54 AM |
| Brainstorm Cell Therapeutics (NASDAQ:BCLI) Shares Gap Down to $6.90
americanbankingnews.com - February 22 at 9:45 AM |
| Head to Head Survey: Enzon Pharmaceuticals (OTCMKTS:ENZN) versus Brainstorm Cell Therapeutics (NASDAQ:BCLI)
americanbankingnews.com - February 20 at 8:24 AM |
| Brainstorm Cell Therapeutics (NASDAQ:BCLI) & Curis (NASDAQ:CRIS) Critical Survey
americanbankingnews.com - February 20 at 2:14 AM |
| Brainstorm Cell Therapeutics (NASDAQ:BCLI) Trading Down 6.3%
americanbankingnews.com - February 18 at 7:46 PM |
|
| We Think Brainstorm Cell Therapeutics (NASDAQ:BCLI) Needs To Drive Business Growth Carefully
finance.yahoo.com - February 6 at 8:45 AM |
| Brainstorm Cell Therapeutics (NASDAQ:BCLI) Stock Price Down 10.5%
americanbankingnews.com - February 5 at 8:10 PM |
| Brainstorm Cell Therapeutics (NASDAQ:BCLI) Announces Quarterly Earnings Results
americanbankingnews.com - February 5 at 1:53 PM |
| BCLI: Waiting for Guidance from FDA on Potential Path Forward for NurOwn® in ALS…
finance.yahoo.com - February 5 at 1:03 PM |
| Why BrainStorm Cell Therapeutics Blasted 27.7% Higher Today
finance.yahoo.com - February 4 at 7:57 PM |
| Brainstorm Cell Therapeutics (NASDAQ:BCLI) Lifted to "Buy" at Maxim Group
americanbankingnews.com - February 4 at 2:56 PM |
| BrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate Update
finance.yahoo.com - February 4 at 9:52 AM |
| BCLI: Preclinical Data Shows NurOwn®-Derived Exosomes Effective in ARDS Model…
finance.yahoo.com - January 25 at 2:49 PM |
 | Brainstorm Cell Therapeutics: What's Left After Recent Trial Failure
seekingalpha.com - January 20 at 3:58 PM |
| BrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn® Derived Exosome-Based Treatment for COVID-19 ARDS
finance.yahoo.com - January 20 at 10:58 AM |
| BrainStorm Announces Completion of All Dosing in NurOwn® Phase 2 MS Study
finance.yahoo.com - December 18 at 7:38 AM |
| BrainStorm Announces NurOwn® Expanded Access Program
finance.yahoo.com - December 14 at 8:57 AM |
| Need To Know: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Insiders Have Been Buying Shares
finance.yahoo.com - December 8 at 9:47 AM |
| Hedge Funds Aren’t Crazy About Brainstorm Cell Therapeutics Inc. (BCLI) Anymore
finance.yahoo.com - November 27 at 12:56 AM |
| BCLI: Phase 3 ALS Trial Does Not Meet Primary Endpoint…
finance.yahoo.com - November 19 at 12:51 PM |
| Why BrainStorm Cell Therapeutics Stock Imploded Today
finance.yahoo.com - November 17 at 1:25 PM |
| BrainStorm Announces Topline Results from NurOwn® Phase 3 ALS Study
finance.yahoo.com - November 17 at 8:25 AM |
| BrainStorm Cell recruits manufacturing partner for stem cell therapies for neurodegenerative disorders
seekingalpha.com - October 26 at 5:57 PM |
| Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility
prnewswire.com - October 26 at 7:56 AM |
| Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility
finance.yahoo.com - October 26 at 7:56 AM |
|
| BCLI: Manufacturing Agreement with Catalent; Recent Sell-off Unwarranted…
finance.yahoo.com - October 23 at 9:50 AM |
| BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Outcomes at the Virtual New York Stem Cell Foundation Conference
finance.yahoo.com - October 19 at 8:58 AM |
| BCLI: Phase 3 ALS Data Due Soon…
finance.yahoo.com - October 16 at 10:48 AM |
| Brainstorm Cell Therapeutics -7% despite earnings beat
seekingalpha.com - October 15 at 5:33 PM |
| Brainstorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - October 15 at 5:33 PM |
| BrainStorm Cell Therapeutics EPS beats by $0.12
seekingalpha.com - October 15 at 7:31 AM |
| BrainStorm to Present at Scientific Conferences in September
finance.yahoo.com - September 3 at 1:17 PM |
| BrainStorm Appoints Pharmaceutical Veteran Anthony Waclawski as Executive Vice President, Global Head of Regulatory Affairs
finance.yahoo.com - September 2 at 12:11 PM |
| BrainStorm to Present Data Linking MRI Measures to Functional Improvement in Progressive Multiple Sclerosis (MS)
finance.yahoo.com - August 25 at 8:59 AM |
| BrainStorm Announces Publication of New Preclinical Data Supporting Proposed NurOwn® Mechanism in ALS, Progressive MS and Alzheimer's Disease
finance.yahoo.com - August 19 at 8:48 AM |
| We're Keeping An Eye On Brainstorm Cell Therapeutics' (NASDAQ:BCLI) Cash Burn Rate
finance.yahoo.com - August 10 at 1:45 PM |
| BrainStorm to Present at the 40th Annual Canaccord Genuity Growth Conference
finance.yahoo.com - August 10 at 8:45 AM |
| BCLI: Phase 3 ALS Data Expected by the End of November 2020…
finance.yahoo.com - August 7 at 1:31 PM |
| Brainstorm Cell Therapeutics Inc (BCLI) CEO Chaim Lebovits on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 1:41 PM |
| BrainStorm Cell Therapeutics EPS beats by $0.01
seekingalpha.com - August 5 at 8:40 AM |
| BrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate Update
finance.yahoo.com - August 5 at 8:40 AM |
| BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D Update
finance.yahoo.com - July 27 at 12:44 PM |
| 5 Stock Gainers for Thursday: Smith & Wesson, Calix, Sunopta
finance.yahoo.com - July 23 at 4:47 PM |
| BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS
finance.yahoo.com - July 23 at 11:45 AM |
| BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share…
finance.yahoo.com - July 9 at 3:06 PM |
